Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Brouwers

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Archives of Neurology|May 1, 1989
Neurologic complications in long-standing nephropathic cystinosisJ K Fink, P Brouwers, N Barton, et al.
Lancet (London, England)|September 1, 1990
Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complexR Yarchoan, J M Pluda, R V Thomas, et al.
The Journal of Nutrition|October 1, 1996
Neurobehavioral manifestations of symptomatic HIV-1 disease in children: can nutritional factors play a role?P Brouwers, C Decarli, M P Heyes, et al.
Lancet (London, England)|January 17, 1987
Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidineR Yarchoan, G Berg, P Brouwers, et al.
The New England Journal of Medicine|October 6, 1988
Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infectionP A Pizzo, J Eddy, J Falloon, et al.
Frontiers in Psychology|January 29, 2019
Measuring the Frequency of Inner-Experience Characteristics by Self-Report: The Nevada Inner Experience QuestionnaireChristopher L Heavey, Stefanie A Moynihan, Vincent P Brouwers, et al.
American Heart Journal|June 7, 2011
Long-term effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria:Ten years of follow-up of Prevention of Renal and Vascular End-stage Disease Intervention Trial (PREVEND IT)Frank P Brouwers, Folkert W Asselbergs, Hans L Hillege, et al.
AIDS (London, England)|August 16, 2001
Protective effect of CCR5 delta 32 heterozygosity is restricted by SDF-1 genotype in children with HIV-1 infectionS Sei, A M Boler, G T Nguyen, et al.
The New England Journal of Medicine|January 17, 1991
Dideoxyinosine in children with symptomatic human immunodeficiency virus infectionK M Butler, R N Husson, F M Balis, et al.
The Journal of Pediatrics|July 1, 1994
Pharmacokinetic evaluation of the combination of zidovudine and didanosine in children with human immunodeficiency virus infectionB U Mueller, P A Pizzo, M Farley, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Archives of Neurology|May 1, 1989
Neurologic complications in long-standing nephropathic cystinosisJ K Fink, P Brouwers, N Barton, et al.
Lancet (London, England)|September 1, 1990
Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complexR Yarchoan, J M Pluda, R V Thomas, et al.
The Journal of Nutrition|October 1, 1996
Neurobehavioral manifestations of symptomatic HIV-1 disease in children: can nutritional factors play a role?P Brouwers, C Decarli, M P Heyes, et al.
Lancet (London, England)|January 17, 1987
Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidineR Yarchoan, G Berg, P Brouwers, et al.
The New England Journal of Medicine|October 6, 1988
Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infectionP A Pizzo, J Eddy, J Falloon, et al.
Frontiers in Psychology|January 29, 2019
Measuring the Frequency of Inner-Experience Characteristics by Self-Report: The Nevada Inner Experience QuestionnaireChristopher L Heavey, Stefanie A Moynihan, Vincent P Brouwers, et al.
American Heart Journal|June 7, 2011
Long-term effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria:Ten years of follow-up of Prevention of Renal and Vascular End-stage Disease Intervention Trial (PREVEND IT)Frank P Brouwers, Folkert W Asselbergs, Hans L Hillege, et al.
AIDS (London, England)|August 16, 2001
Protective effect of CCR5 delta 32 heterozygosity is restricted by SDF-1 genotype in children with HIV-1 infectionS Sei, A M Boler, G T Nguyen, et al.
The New England Journal of Medicine|January 17, 1991
Dideoxyinosine in children with symptomatic human immunodeficiency virus infectionK M Butler, R N Husson, F M Balis, et al.
The Journal of Pediatrics|July 1, 1994
Pharmacokinetic evaluation of the combination of zidovudine and didanosine in children with human immunodeficiency virus infectionB U Mueller, P A Pizzo, M Farley, et al.
Pageof 11